Quick summary

Tinospora cordifolia, commonly known as Guduchi, is a traditional Ayurvedic herb used for various therapeutic purposes. Clinical evidence suggests potential benefits in managing type 2 diabetes mellitus and as an adjunct in COVID-19 treatment protocols, with emerging data on hepatoprotective effects. However, some reports of herb-induced liver injury (hepatotoxicity) emphasize the need for cautious use. Currently available human clinical evidence is limited by methodological quality and small sample sizes, and safety concerns warrant further study.

What is it

Guduchi (Tinospora cordifolia) is a climbing shrub native to the Indian subcontinent and other tropical regions. It has been used for centuries in Ayurveda, the traditional system of Indian medicine, primarily for its supposed immune-modulating and health-promoting properties. The plant parts commonly used include the stem and leaves, typically prepared as extracts, powders, or decoctions.

Traditional uses

Traditionally, Guduchi has been employed in Ayurveda for enhancing immunity, treating fever, digestive disorders, diabetes, respiratory issues, and as a general tonic for longevity and vitality. It is also used in formulations aimed at detoxification and rejuvenation (Rasayana therapy).

Active compounds

Guduchi contains several bioactive compounds, including alkaloids (e.g., berberine, palmatine), diterpenoid lactones (e.g., tinosporide), glycosides, steroids, and polysaccharides. These constituents are thought to contribute to its immunomodulatory, anti-inflammatory, antioxidant, and possible hepatoprotective activities.

Potential benefits with evidence levels

  • Management of type 2 diabetes mellitus (Moderate to low certainty): Systematic reviews and randomized controlled trials indicate that Tinospora cordifolia may reduce glycated hemoglobin (HbA1c) and fasting blood glucose in patients with type 2 diabetes, suggesting possible improvement in glycemic control. However, the methodological quality of these studies is suboptimal, limiting firm conclusions.
  • COVID-19 prophylaxis and adjunct therapy (Low to moderate certainty): Meta-analyses of clinical trials involving Ayurvedic medicines, including Guduchi, suggest a possible reduction in incidence and severity of COVID-19 infection when used prophylactically or as an adjunct therapy in mild-to-moderate cases. The evidence is limited by risk of bias and study heterogeneity.
  • Prevention of anti-tuberculosis drug-induced liver injury (Low certainty): Network meta-analysis indicates that supplementation with Turmeric plus Tinospora cordifolia may reduce the incidence of liver injury related to anti-tuberculosis treatment compared to placebo. Nonetheless, the number of studies and sample sizes are limited, warranting cautious interpretation.

Side effects

Guduchi is generally well tolerated in the short term, with most reported adverse effects being mild gastrointestinal symptoms such as nausea or diarrhea. However, there are documented cases of herb-induced autoimmune-like hepatitis and acute liver failure associated with its use, often linked to contaminated or adulterated products. Adverse event reporting in clinical trials is inconsistent and incomplete.

Drug interactions

No conclusive human clinical data are available regarding drug interactions of Tinospora cordifolia. Given reports of potential hepatic adverse effects, caution is advised when Guduchi is co-administered with hepatotoxic drugs, including anti-tuberculosis agents.

Who should avoid it

Because of potential hepatotoxicity, individuals with pre-existing liver disease or those taking other hepatotoxic medications should approach Guduchi use cautiously. There is insufficient evidence regarding safety during pregnancy and breastfeeding; therefore, use is generally not recommended during these periods. Specific contraindications have not been well established due to limited clinical data.

Evidence limitations

Current evidence is limited by small sample sizes, heterogeneous study designs, and varying doses and formulations. Many studies suffer from poor reporting of randomization and blinding methods, incomplete monitoring of adverse events, and lack of long-term safety data. Moderate to high risk of bias reduces confidence in the reported outcomes. Data on drug interactions and effects in special populations are lacking.

References

Last reviewed

June 2024

Disclaimer

This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a healthcare professional before starting any new herbal supplement, especially if you have pre-existing health conditions, are pregnant, breastfeeding, or are taking other medications.